• 

  August 29, 2025

  Treatment & Management of Colon Cancer

  Charles H. Weaver, MD

• 

  August 29, 2025

  Treatment of Stage I – III Colon Cancer

  Charles H. Weaver, MD

• 

  August 28, 2025

  Personalized ctDNA MRD Testing Improves Outcomes in Muscle-Invasive Bladder Cancer

  Charles H. Weaver, MD

• 

  August 28, 2025

  MRD ctDNA Surveillance for Breast Cancer Recurrence

  Charles H. Weaver, MD

• 

  June 28, 2025

  Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging

  Charles H. Weaver, MD

• 

  February 21, 2025

  Overall Lonsurf Did not Lead to Significant Improvement in Disease Free Survival in ctDNA- Positive Colorectal Cancer

  Charles H. Weaver, MD

• 

  August 9, 2024

  Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer

  Charles H. Weaver, MD

• 

  August 9, 2024

  Ask The Expert About Immunotherapy Treatment for Melanoma

  Charles H. Weaver, MD

• 

  December 9, 2020

  Liquid Biopsies Improve Treatment of Lung Cancer

  Charles H. Weaver, MD

• 

  August 30, 2019

  The CA 125 “tumor associated protein” or “tumor marker”

  Charles H. Weaver, MD

• 

  September 8, 2018

  What Is a Liquid Biopsy?

  Charles H. Weaver, MD

• 

  January 1, 2012

  It’s In the Genes-Genetics & Cancer

  Charles H. Weaver, MD